FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

12207811000001100: Atriance 250mg/50ml solution for infusion vials (GlaxoSmithKline) 6 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
44003701000001119 Atriance 250mg/50ml solution for infusion vials (GlaxoSmithKline) 6 vial (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
92704601000001110 Atriance 250mg/50ml solution for infusion vials (Novartis Pharmaceuticals UK Ltd) 6 vial en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Atriance 250mg/50ml solution for infusion vials (GlaxoSmithKline) 6 vial Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Atriance 250mg/50ml solution for infusion vials (GlaxoSmithKline) 6 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Atriance 250mg/50ml solution for infusion vials (GlaxoSmithKline) 6 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Atriance 250mg/50ml solution for infusion vials (GlaxoSmithKline) 6 vial Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Atriance 250mg/50ml solution for infusion vials (GlaxoSmithKline) 6 vial Is a Nelarabine 250mg/50ml solution for injection vials 6 vial true Inferred relationship Existential restriction modifier
Atriance 250mg/50ml solution for infusion vials (GlaxoSmithKline) 6 vial Is pack of Atriance 250mg/50ml solution for infusion vials (GlaxoSmithKline) false Inferred relationship Existential restriction modifier
Atriance 250mg/50ml solution for infusion vials (GlaxoSmithKline) 6 vial Has active ingredient Nelarabine false Inferred relationship Existential restriction modifier
Atriance 250mg/50ml solution for infusion vials (GlaxoSmithKline) 6 vial Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Atriance 250mg/50ml solution for infusion vials (GlaxoSmithKline) 6 vial Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Atriance 250mg/50ml solution for infusion vials (GlaxoSmithKline) 6 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Atriance 250mg/50ml solution for infusion vials (GlaxoSmithKline) 6 vial VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Atriance 250mg/50ml solution for infusion vials (GlaxoSmithKline) 6 vial Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Atriance 250mg/50ml solution for infusion vials (GlaxoSmithKline) 6 vial Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Atriance 250mg/50ml solution for infusion vials (GlaxoSmithKline) 6 vial Has AMP Atriance 250mg/50ml solution for infusion vials (GlaxoSmithKline) true Inferred relationship Existential restriction modifier
Atriance 250mg/50ml solution for infusion vials (GlaxoSmithKline) 6 vial Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Atriance 250mg/50ml solution for infusion vials (GlaxoSmithKline) 6 vial Has specific active ingredient Nelarabine true Inferred relationship Existential restriction modifier
Atriance 250mg/50ml solution for infusion vials (GlaxoSmithKline) 6 vial Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start